Compound details
L-Phenylalanine
| Compound ID | CDAMM00256 |
|---|---|
| Common name | L-Phenylalanine | IUPAC name | (2S)-2-amino-3-phenylpropanoic acid |
| Molecular formula | C9H11NO2 |
| Retention time | 15.739 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 166.087 | Theoretical mz | 166.086 |
| Error | 2.67 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.57 |
| Inchi key | BLGXFZZNTVWLAY-SCYLSFHTSA-N |
|---|---|
| Smiles | C1=CC=C(C=C1)CC(C(=O)O)N |
| Superclass | Alkaloids and derivatives |
| Class | Yohimbine alkaloids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P06241 | FYN | Tyrosine-protein kinase FYN | T17980 | SwissTargetPrediction |
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| Q86X55 | CARM1 | Histone-arginine methyltransferase CARM1 | T12837 | SEA |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SEA |
| P29475 | NOS1 | Nitric-oxide synthase, brain | T16117 | SEA |
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SEA |
| P29474 | NOS3 | Nitric-oxide synthase, endothelial | T06046 | SEA |
| Q16853 | AOC3 | Amine oxidase, copper containing | T69619 | SEA |
| Q99720 | SIGMAR1 | Sigma opioid receptor | T46360 | SEA |
| P24046 | GABRR1 | GABA receptor rho-1 subunit | T99665 | SwissTargetPrediction |
| P15144 | ANPEP | Aminopeptidase N | T67272 | SwissTargetPrediction and SEA |
| O75899 | GABBR2 | GABA-B receptor | T42446 | SwissTargetPrediction |
| P00734 | F2 | Thrombin | T94033 | SEA |
| P09960 | LTA4H | Leukotriene A4 hydrolase | T03691 | SEA |
| O75899 | GABBR2 | GABA-B receptor | T42446 | SwissTargetPrediction |
| P54289 | CACNA2D1 | Voltage-gated calcium channel alpha2/delta subunit 1 (by homology) | T84316 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| Q14833 | GRM4 | Metabotropic glutamate receptor 4 | T99402 | SEA |
| O00222 | GRM8 | Metabotropic glutamate receptor 8 | T77548 | SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SEA |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SEA |
| P06239 | LCK | Tyrosine-protein kinase LCK | T12499 | SwissTargetPrediction |
| Q9NTG7 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | T91959 | SEA |
| Q8IXJ6 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | T83904 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P08514 | ITGA2B | Integrin alpha-IIb/beta-3 | T50688 | SEA |
| P27487 | DPP4 | Dipeptidyl peptidase IV | T31391 | SEA |
| P98170 | XIAP | Inhibitor of apoptosis protein 3 | T16769 | SEA |
| P08473 | MME | Neprilysin | T05409 | SEA |
| P34913 | EPHX2 | Epoxide hydratase | T35734 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| O60341 | KDM1A | Lysine-specific histone demethylase 1 | T16739 | SwissTargetPrediction |
| P31645 | SLC6A4 | Serotonin transporter (by homology) | T27812 | SwissTargetPrediction |
| Q96RJ0 | TAAR1 | Trace amine-associated receptor 1 (by homology) | T99524 | SwissTargetPrediction and SEA |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SwissTargetPrediction |
| P43005 | SLC1A1 | Excitatory amino acid transporter 3 | T31721 | SEA |
| P39086 | GRIK1 | Glutamate receptor ionotropic kainate 1 | T73495 | SEA |
| Q13002 | GRIK2 | Glutamate receptor ionotropic kainate 2 | T58178 | SEA |
| Q14832 | GRM3 | Metabotropic glutamate receptor 3 | T02719 | SEA |
| O15303 | GRM6 | Metabotropic glutamate receptor 6 | T55956 | SEA |
| P42261 | GRIA1 | Glutamate receptor ionotropic, AMPA 1 | T33584 | SEA |
| Q16478 | GRIK5 | Glutamate receptor ionotropic kainate 5 | T87930 | SEA |
| Q13003 | GRIK3 | Glutamate receptor ionotropic kainate 3 | T68876 | SEA |
| P42262 | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | T42392 | SEA |
| P43235 | CTSK | Cathepsin K | T11388 | SEA |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SEA |
| Q9H3R0 | KDM4C | Lysine-specific demethylase 4C | T73863 | SwissTargetPrediction |
| P23141 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | T76369 | SEA |
| P10145 | CXCL8 | Interleukin-8 | T22658 | SEA |
| Q9H4A4 | RNPEP | Aminopeptidase B | T57818 | SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SwissTargetPrediction |
| Q96IY4 | CPB2 | Carboxypeptidase B2 isoform A | T98022 | SwissTargetPrediction and SEA |
| P12955 | PEPD | Xaa-Pro dipeptidase | T94823 | SwissTargetPrediction and SEA |
| O15229 | KMO | Kynurenine 3-monooxygenase | T50973 | SEA |
| P07101 | TH | Tyrosine 3-hydroxylase | T62390 | SwissTargetPrediction and SEA |
| Q16719 | KYNU | Kynureninase | T99912 | SEA |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SEA |
| Q07075 | ENPEP | Aminopeptidase A | T31956 | SwissTargetPrediction and SEA |
| Q01650 | SLC7A5 | L-type amino acid transporter 1 (by homology) | T48330 | SwissTargetPrediction and SEA |
| P14902 | IDO1 | Indoleamine 2,3-dioxygenase | T89697 | SEA |
| Q07869 | PPARA | Peroxisome proliferator-activated receptor alpha | T86591 | SEA |
| Q03181 | PPARD | Peroxisome proliferator-activated receptor delta | T36557 | SEA |
| O14842 | FFAR1 | Free fatty acid receptor 1 | T25608 | SEA |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SEA |
| P22894 | MMP8 | Matrix metalloproteinase 8 | T08856 | SEA |
| P08254 | MMP3 | Matrix metalloproteinase 3 | T86702 | SEA |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SEA |
| P09917 | ALOX5 | Arachidonate 5-lipoxygenase | T00140 | SEA |
| P03956 | MMP1 | Matrix metalloproteinase 1 | T52450 | SEA |
| P17655 | CAPN2 | Calpain 2 | T86837 | SEA |
| P23975 | SLC6A2 | Norepinephrine transporter | T21945 | SwissTargetPrediction |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SEA |
| P41145 | OPRK1 | Kappa Opioid receptor | T60693 | SEA |
| P10827 | THRA | Thyroid hormone receptor alpha | T79591 | SEA |
| P10828 | THRB | Thyroid hormone receptor beta-1 | T98933 | SEA |
| P27695 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | T13348 | SEA |
| P15086 | CPB1 | Carboxypeptidase B | T36725 | SEA |
| P52732 | KIF11 | Kinesin-like protein 1 | T28484 | SEA |
| P09237 | MMP7 | Matrix metalloproteinase 7 | T73475 | SEA |
| P35270 | SPR | Substance-P receptor | T47094 | SwissTargetPrediction and SEA |
| P04229 | HLA-DRB1 | HLA class II histocompatibility antigen DRB1-1 | T83611 | SEA |
| P07711 | CTSL | Cathepsin L | T98691 | SEA |
| P07858 | CTSB | Cathepsin (B and K) | T61746 | SEA |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SEA |
| P23946 | CMA1 | Chymase | T05114 | SEA |
| P37231 | PPARG | Peroxisome proliferator-activated receptor gamma | T58921 | SEA |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SEA |
| Q9UHL4 | DPP7 | Dipeptidyl peptidase II | T50773 | SEA |
| P35348 | ADRA1A | Alpha-1a adrenergic receptor | T92609 | SwissTargetPrediction |
| P31749 | AKT1 | Serine/threonine-protein kinase AKT | T67619 | SEA |
| Q12884 | FAP | Fibroblast activation protein alpha (by homology) | T53764 | SEA |
| P25774 | CTSS | Cathepsin S | T68290 | SEA |
| P09211 | GSTP1 | Glutathione S-transferase Pi | T21669 | SEA |
| Q6P179 | ERAP2 | Endoplasmic reticulum aminopeptidase 2 | T65818 | SEA |
| P06870 | KLK1 | Kallikrein 1 | T40000 | SEA |
| P20151 | KLK2 | Kallikrein 2 | T01908 | SEA |
| P48039 | MTNR1A | Melatonin receptor 1A | T97613 | SEA |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SEA |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SwissTargetPrediction |
| P00813 | ADA | Adenosine deaminase | T03661 | SEA |
| P04439 | HLA-A | HLA class I histocompatibility antigen A-3 | T08985 | SEA |
| P50579 | METAP2 | Methionine aminopeptidase 2 | T75596 | SEA |
| Q9ULA0 | DNPEP | Aspartyl aminopeptidase | T45287 | SEA |
| Q9BYF1 | ACE2 | Angiotensin-converting enzyme 2 | T27889 | SEA |
| P42892 | ECE1 | Endothelin-converting enzyme 1 | T50970 | SEA |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SEA |
| P05556 | ITGB1 | Integrin alpha2/beta1 | T01851 | SEA |
| Q9ULW8 | PADI3 | Protein-arginine deiminase type-3 | T36612 | SEA |
| Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | T50429 | SEA |
| P15085 | CPA1 | Carboxypeptidase A1 | T33966 | SEA |
| Q99895 | CTRC | Chymotrypsin C | T10118 | SEA |
| P31751 | AKT2 | Serine/threonine-protein kinase AKT2 | T94621 | SEA |
| Q9Y243 | AKT3 | Serine/threonine-protein kinase AKT | T71266 | SEA |
| Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | T30219 | SEA |
| P03952 | KLKB1 | Plasma kallikrein | T82739 | SEA |
| O60760 | HPGDS | Hematopoietic prostaglandin D synthase | T19433 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| P43003 | SLC1A3 | Excitatory amino acid transporter 1 | T86582 | SEA |
| P46059 | SLC15A1 | Oligopeptide transporter small intestine isoform | T91180 | SwissTargetPrediction |
| Q9Y3Q0 | NAALAD2 | NAALADase II | T70036 | SEA |
| Q92820 | GGH | Gamma-glutamyl hydrolase | T71646 | SEA |
| O15151 | MDM4 | Protein Mdm4 | T36741 | SEA |
| Q14524 | SCN5A | Sodium channel protein type V alpha subunit | T39716 | SEA |
| Q13526 | PIN1 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | T16308 | SEA |
| P29371 | TACR3 | Neurokinin 3 receptor | T29683 | SEA |
| Q9UIQ6 | LNPEP | Cystinyl aminopeptidase | T97537 | SEA |
| P41240 | CSK | Tyrosine-protein kinase CSK | T08741 | SEA |
| Q9UK32 | RPS6KA6 | Ribosomal protein S6 kinase alpha 6 | T95878 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| P20248 | CCNA2 | CDK2/Cyclin A | T58470 | SEA |
| P03951 | F11 | Coagulation factor XI | T46040 | SEA |
| Q9UNI1 | CELA1 | Elastase 1 | T22839 | SEA |
| P53634 | CTSC | Dipeptidyl peptidase I | T70490 | SEA |
| O75908 | SOAT2 | Acyl coenzyme A:cholesterol acyltransferase 2 | T14463 | SEA |
| Q9H1C0 | LPAR5 | Lysophosphatidic acid receptor 5 | T18616 | SEA |
| P05089 | ARG1 | Arginase-1 (by homology) | T63224 | SEA |
| P06734 | FCER2 | Immunoglobulin epsilon Fc receptor | T67207 | SEA |
| P12004 | PCNA | Proliferating cell nuclear antigen | T21782 | SEA |
| P13612 | ITGA4 | Integrin alpha-4 | T97587 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | T99340 | SEA |
| P21462 | FPR1 | Formyl peptide receptor 1 | T87831 | SEA |
| Q03405 | PLAUR | Urokinase plasminogen activator surface receptor | T74363 | SEA |
| Q6DWJ6 | GPR139 | Probable G-protein coupled receptor 139 | T84439 | SEA |
| Q9Y337 | KLK5 | Kallikrein 5 | T11808 | SEA |
| P08311 | CTSG | Cathepsin G | T86385 | SEA |
| P35499 | SCN4A | Sodium channel protein type IV alpha subunit | T02546 | SEA |
| Q16881 | TXNRD1 | Thioredoxin reductase 1 | T84581 | SEA |
| P15169 | CPN1 | Carboxypeptidase N, catalytic subunit | T34471 | SEA |
| O43895 | XPNPEP2 | Xaa-Pro aminopeptidase 2 | T68320 | SEA |
| P09668 | CTSH | Cathepsin (H and K) | T40103 | SEA |
| O95822 | MLYCD | Malonyl-CoA decarboxylase | T98078 | SEA |
| O95551 | TDP2 | Tyrosyl-DNA phosphodiesterase 2 | T04696 | SEA |
| Q99571 | P2RX4 | P2X purinoceptor 4 | T60330 | SEA |
| Q8IWU9 | TPH2 | Tryptophan hydroxylase | T51593 | SEA |
| Q9UPY5 | SLC7A11 | Cystine/glutamate transporter | T11615 | SEA |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| Q6V1X1 | DPP8 | Dipeptidyl peptidase VIII | T15855 | SEA |
| Q86TI2 | DPP9 | Dipeptidyl peptidase IX | T66252 | SEA |
| Q9BWQ3 | ASCT2 | Alanine/serine/cysteine transporter 2 | T59493 | SEA |
| Q9GZQ6 | NPFFR1 | Neuropeptide FF receptor 1 | T79780 | SEA |
| Q9Y5X5 | NPFFR2 | Neuropeptide FF receptor 2 | T90818 | SEA |
| O60259 | KLK8 | Neuropsin | T43289 | SEA |
| Q9BY41 | HDAC8 | Histone deacetylase 8 | T28887 | SEA |
| Q9Y5K2 | KLK4 | Kallikrein-4 | T79400 | SEA |
| P37088 | SCNN1A | Amiloride-sensitive sodium channel | T52173 | SEA |
| P04632 | CAPNS1 | HUMAN calpain-1 or calpain small subunit 1 heterodimer | T00099 | SEA |
| P00480 | OTC | Ornithine transcarbamylase | T52098 | SEA |
| P42263 | GRIA3 | Glutamate receptor AMPA 3 | T62391 | SEA |
| Q6ZQN7 | SLCO4C1 | Organic anion transporter M1 | T36053 | SEA |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SEA |
| Q8IWU9 | TPH2 | Tryptophan hydroxylase | T51593 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T17980 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06241 | FYN |
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T16117 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P29475 | NOS1 |
| T16117 | DI0264 | Migraine | [ICD-11: 8A80] | P29475 | NOS1 |
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T06046 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P29474 | NOS3 |
| T69619 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q16853 | AOC3 |
| T46360 | DI0105 | Cough | [ICD-11: MD12] | Q99720 | SIGMAR1 |
| T67272 | DI0351 | Psoriasis | [ICD-11: EA90] | P15144 | ANPEP |
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T94033 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00734 | F2 |
| T94033 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00734 | F2 |
| T94033 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P00734 | F2 |
| T94033 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P00734 | F2 |
| T94033 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00734 | F2 |
| T94033 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00734 | F2 |
| T94033 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P00734 | F2 |
| T94033 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00734 | F2 |
| T03691 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P09960 | LTA4H |
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T84316 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P54289 | CACNA2D1 |
| T84316 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P54289 | CACNA2D1 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T99402 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q14833 | GRM4 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T12499 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06239 | LCK |
| T83904 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q8IXJ6 | SIRT2 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T50688 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P08514 | ITGA2B |
| T50688 | DI0030 | Angina pectoris | [ICD-11: BA40] | P08514 | ITGA2B |
| T50688 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08514 | ITGA2B |
| T31391 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P27487 | DPP4 |
| T31391 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P27487 | DPP4 |
| T16769 | DI0259 | Metastatic lymph node neoplasm | [ICD-11: 2D60] | P98170 | XIAP |
| T05409 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08473 | MME |
| T35734 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P34913 | EPHX2 |
| T35734 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P34913 | EPHX2 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T16739 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O60341 | KDM1A |
| T16739 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O60341 | KDM1A |
| T16739 | DI0138 | Ewing sarcoma | [ICD-11: 2B52] | O60341 | KDM1A |
| T16739 | DI0238 | Lung cancer | [ICD-11: 2C25] | O60341 | KDM1A |
| T16739 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O60341 | KDM1A |
| T16739 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O60341 | KDM1A |
| T16739 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O60341 | KDM1A |
| T16739 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60341 | KDM1A |
| T16739 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O60341 | KDM1A |
| T27812 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P31645 | SLC6A4 |
| T27812 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P31645 | SLC6A4 |
| T27812 | DI0087 | Chronic pain | [ICD-11: MG30] | P31645 | SLC6A4 |
| T27812 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P31645 | SLC6A4 |
| T27812 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P31645 | SLC6A4 |
| T27812 | DI0105 | Cough | [ICD-11: MD12] | P31645 | SLC6A4 |
| T27812 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P31645 | SLC6A4 |
| T27812 | DI0264 | Migraine | [ICD-11: 8A80] | P31645 | SLC6A4 |
| T27812 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P31645 | SLC6A4 |
| T27812 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P31645 | SLC6A4 |
| T27812 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P31645 | SLC6A4 |
| T99524 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q96RJ0 | TAAR1 |
| T99524 | DI0149 | Focal/segmental autonomic disorder | [ICD-11: 8D8A] | Q96RJ0 | TAAR1 |
| T99524 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q96RJ0 | TAAR1 |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T73495 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P39086 | GRIK1 |
| T73495 | DI0396 | Substance abuse | [ICD-11: 6C40] | P39086 | GRIK1 |
| T02719 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q14832 | GRM3 |
| T33584 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42261 | GRIA1 |
| T42392 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42262 | GRIA2 |
| T11388 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P43235 | CTSK |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T76369 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P23141 | CES1 |
| T76369 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P23141 | CES1 |
| T22658 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P10145 | CXCL8 |
| T98022 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | Q96IY4 | CPB2 |
| T98022 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | Q96IY4 | CPB2 |
| T98022 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | Q96IY4 | CPB2 |
| T62390 | DI0019 | Adrenomedullary hyperfunction | [ICD-11: 5A75] | P07101 | TH |
| T62390 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P07101 | TH |
| T99912 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q16719 | KYNU |
| T99912 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q16719 | KYNU |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T31956 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q07075 | ENPEP |
| T89697 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14902 | IDO1 |
| T86591 | DI0187 | Hyperlipidemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q07869 | PPARA |
| T36557 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | Q03181 | PPARD |
| T36557 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q03181 | PPARD |
| T25608 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | O14842 | FFAR1 |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T08856 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P22894 | MMP8 |
| T86702 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P08254 | MMP3 |
| T86702 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P08254 | MMP3 |
| T86702 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P08254 | MMP3 |
| T86702 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P08254 | MMP3 |
| T86702 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08254 | MMP3 |
| T86702 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P08254 | MMP3 |
| T86702 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P08254 | MMP3 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T00140 | DI0037 | Asthma | [ICD-11: CA23] | P09917 | ALOX5 |
| T00140 | DI0147 | Filariasis | [ICD-11: 1F66] | P09917 | ALOX5 |
| T00140 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09917 | ALOX5 |
| T52450 | DI0238 | Lung cancer | [ICD-11: 2C25] | P03956 | MMP1 |
| T86837 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P17655 | CAPN2 |
| T21945 | DI0013 | Acute pain | [ICD-11: MG31] | P23975 | SLC6A2 |
| T21945 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P23975 | SLC6A2 |
| T21945 | DI0087 | Chronic pain | [ICD-11: MG30] | P23975 | SLC6A2 |
| T21945 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P23975 | SLC6A2 |
| T21945 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P23975 | SLC6A2 |
| T21945 | DI0166 | Glaucoma | [ICD-11: 9C61] | P23975 | SLC6A2 |
| T21945 | DI0264 | Migraine | [ICD-11: 8A80] | P23975 | SLC6A2 |
| T21945 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P23975 | SLC6A2 |
| T21945 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P23975 | SLC6A2 |
| T21945 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P23975 | SLC6A2 |
| T21945 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P23975 | SLC6A2 |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T60693 | DI0304 | Non-specific cutaneous vascular symptom | [ICD-11: ME64] | P41145 | OPRK1 |
| T60693 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41145 | OPRK1 |
| T60693 | DI0349 | Pruritus | [ICD-11: EC90] | P41145 | OPRK1 |
| T79591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10827 | THRA |
| T79591 | DI0197 | Hypo-thyroidism | [ICD-11: 5A00] | P10827 | THRA |
| T98933 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10828 | THRB |
| T13348 | DI0365 | Retinopathy | [ICD-11: 9B71] | P27695 | APEX1 |
| T13348 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P27695 | APEX1 |
| T28484 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P52732 | KIF11 |
| T28484 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | P52732 | KIF11 |
| T28484 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P52732 | KIF11 |
| T28484 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P52732 | KIF11 |
| T28484 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P52732 | KIF11 |
| T28484 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P52732 | KIF11 |
| T28484 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P52732 | KIF11 |
| T28484 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P52732 | KIF11 |
| T73475 | DI0238 | Lung cancer | [ICD-11: 2C25] | P09237 | MMP7 |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T83611 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04229 | HLA-DRB1 |
| T98691 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P07711 | CTSL |
| T98691 | DI0376 | Severe acute respiratory syndrome | [ICD-11: 1D65] | P07711 | CTSL |
| T61746 | DI0023 | Alopecia | [ICD-11: ED70] | P07858 | CTSB |
| T61746 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P07858 | CTSB |
| T61746 | DI0037 | Asthma | [ICD-11: CA23] | P07858 | CTSB |
| T61746 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | P07858 | CTSB |
| T61746 | DI0060 | Brain cancer | [ICD-11: 2A00] | P07858 | CTSB |
| T61746 | DI0067 | Cardiac arrest | [ICD-11: MC82] | P07858 | CTSB |
| T61746 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P07858 | CTSB |
| T61746 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07858 | CTSB |
| T61746 | DI0087 | Chronic pain | [ICD-11: MG30] | P07858 | CTSB |
| T61746 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P07858 | CTSB |
| T61746 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P07858 | CTSB |
| T61746 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P07858 | CTSB |
| T61746 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P07858 | CTSB |
| T61746 | DI0253 | Meningioma | [ICD-11: 2A01] | P07858 | CTSB |
| T61746 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P07858 | CTSB |
| T61746 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07858 | CTSB |
| T61746 | DI0296 | Neurodegenerative disorder | [ICD-11: 8A20-8A23] | P07858 | CTSB |
| T61746 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P07858 | CTSB |
| T61746 | DI0351 | Psoriasis | [ICD-11: EA90] | P07858 | CTSB |
| T61746 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P07858 | CTSB |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T05114 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23946 | CMA1 |
| T05114 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P23946 | CMA1 |
| T05114 | DI0169 | Gram-positive bacterial infection | [ICD-11: 1B74-1F40] | P23946 | CMA1 |
| T05114 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P23946 | CMA1 |
| T05114 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P23946 | CMA1 |
| T05114 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P23946 | CMA1 |
| T58921 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P37231 | PPARG |
| T58921 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P37231 | PPARG |
| T58921 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P37231 | PPARG |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T92609 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35348 | ADRA1A |
| T92609 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P35348 | ADRA1A |
| T67619 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P31749 | AKT1 |
| T53764 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q12884 | FAP |
| T68290 | DI0042 | Autoimmune disease | [ICD-11: 4A40-4A45] | P25774 | CTSS |
| T68290 | DI0092 | Coeliac disease | [ICD-11: DA95] | P25774 | CTSS |
| T68290 | DI0107 | Crohn disease | [ICD-11: DD70] | P25774 | CTSS |
| T68290 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P25774 | CTSS |
| T68290 | DI0163 | General pain disorder | [ICD-11: 8E43] | P25774 | CTSS |
| T68290 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25774 | CTSS |
| T68290 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P25774 | CTSS |
| T21669 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P09211 | GSTP1 |
| T01908 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P20151 | KLK2 |
| T97613 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P48039 | MTNR1A |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T03661 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P00813 | ADA |
| T03661 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P00813 | ADA |
| T03661 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P00813 | ADA |
| T75596 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50579 | METAP2 |
| T45287 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q9ULA0 | DNPEP |
| T27889 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q9BYF1 | ACE2 |
| T27889 | DI0217 | Intrathoracic organs injury | [ICD-11: NB32] | Q9BYF1 | ACE2 |
| T27889 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | Q9BYF1 | ACE2 |
| T01851 | DI0060 | Brain cancer | [ICD-11: 2A00] | P05556 | ITGB1 |
| T01851 | DI0238 | Lung cancer | [ICD-11: 2C25] | P05556 | ITGB1 |
| T01851 | DI0365 | Retinopathy | [ICD-11: 9B71] | P05556 | ITGB1 |
| T71266 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9Y243 | AKT3 |
| T82739 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P03952 | KLKB1 |
| T82739 | DI0364 | Retinal vascular occlusion | [ICD-11: 9B74] | P03952 | KLKB1 |
| T19433 | DI0148 | Flatworm infection | [ICD-11: 1F70-1F86] | O60760 | HPGDS |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T36741 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O15151 | MDM4 |
| T36741 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O15151 | MDM4 |
| T36741 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O15151 | MDM4 |
| T36741 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15151 | MDM4 |
| T39716 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q14524 | SCN5A |
| T39716 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | Q14524 | SCN5A |
| T39716 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q14524 | SCN5A |
| T39716 | DI0105 | Cough | [ICD-11: MD12] | Q14524 | SCN5A |
| T39716 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | Q14524 | SCN5A |
| T39716 | DI0264 | Migraine | [ICD-11: 8A80] | Q14524 | SCN5A |
| T39716 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q14524 | SCN5A |
| T39716 | DI0434 | Ventricular tachyarrhythmia | [ICD-11: BC71] | Q14524 | SCN5A |
| T16308 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q13526 | PIN1 |
| T29683 | DI0254 | Menopausal disorder | [ICD-11: GA30] | P29371 | TACR3 |
| T95878 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q9UK32 | RPS6KA6 |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T58470 | DI0363 | Retina cancer | [ICD-11: 2D02] | P20248 | CCNA2 |
| T46040 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P03951 | F11 |
| T46040 | DI0089 | Clotting disorder | [ICD-11: 3B4Z] | P03951 | F11 |
| T22839 | DI0024 | Alpha-1-antitrypsin deficiency | [ICD-11: 5C5A] | Q9UNI1 | CELA1 |
| T22839 | DI0065 | Bronchitis | [ICD-11: CA20] | Q9UNI1 | CELA1 |
| T70490 | DI0064 | Bronchiectasis | [ICD-11: CA24] | P53634 | CTSC |
| T14463 | DI0017 | Adrenal cancer | [ICD-11: 2D11] | O75908 | SOAT2 |
| T63224 | DI0258 | Metabolism inborn error | [ICD-11: 5C50] | P05089 | ARG1 |
| T67207 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P06734 | FCER2 |
| T21782 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P12004 | PCNA |
| T97587 | DI0107 | Crohn disease | [ICD-11: DD70] | P13612 | ITGA4 |
| T97587 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P13612 | ITGA4 |
| T97587 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P13612 | ITGA4 |
| T99340 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q13546 | RIPK1 |
| T99340 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q13546 | RIPK1 |
| T99340 | DI0273 | Motor neuron disease | [ICD-11: 8B60] | Q13546 | RIPK1 |
| T99340 | DI0295 | Nervous system paraneoplastic/autoimmune disorder | [ICD-11: 8E4A] | Q13546 | RIPK1 |
| T99340 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | Q13546 | RIPK1 |
| T99340 | DI0351 | Psoriasis | [ICD-11: EA90] | Q13546 | RIPK1 |
| T99340 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q13546 | RIPK1 |
| T99340 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q13546 | RIPK1 |
| T87831 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P21462 | FPR1 |
| T74363 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | Q03405 | PLAUR |
| T74363 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | Q03405 | PLAUR |
| T84439 | DI0377 | Sex development malformative disorder | [ICD-11: LD2A] | Q6DWJ6 | GPR139 |
| T86385 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P08311 | CTSG |
| T02546 | DI0281 | Musculoskeletal disorder | [ICD-11: FA00-FC0Z] | P35499 | SCN4A |
| T84581 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16881 | TXNRD1 |
| T51593 | DI0066 | Carcinoid syndrome | [ICD-11: 5B10] | Q8IWU9 | TPH2 |
| T51593 | DI0389 | Small intestine developmental anomaly | [ICD-11: DA90] | Q8IWU9 | TPH2 |
| T11615 | DI0054 | Body-focused behaviour disorder | [ICD-11: 6B25] | Q9UPY5 | SLC7A11 |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T15855 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q6V1X1 | DPP8 |
| T66252 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q86TI2 | DPP9 |
| T28887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BY41 | HDAC8 |
| T52173 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P37088 | SCNN1A |
| T52173 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P37088 | SCNN1A |
| T52173 | DI0311 | Oedema | [ICD-11: MG29] | P37088 | SCNN1A |
| T00099 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P04632 | CAPNS1 |
| T52098 | DI0258 | Metabolism inborn error | [ICD-11: 5C50] | P00480 | OTC |
| T62391 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42263 | GRIA3 |
| T36053 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | Q6ZQN7 | SLCO4C1 |
| T36053 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q6ZQN7 | SLCO4C1 |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T51593 | DI0066 | Carcinoid syndrome | [ICD-11: 5B10] | Q8IWU9 | TPH2 |
| T51593 | DI0389 | Small intestine developmental anomaly | [ICD-11: DA90] | Q8IWU9 | TPH2 |